Will all stocks win in the high-growth cannabis industry?
Not all stocks will be winners in the high-growth cannabis industry. A Fool since 2010, and a graduate from UC San Diego with a B.A. in Economics, Sean specializes in the healthcare sector and investment planning.
Is there a silver lining in the pot Stock Market sell-off?
While the current market sell-off has affected many pot stocks over the past days, there could be a silver lining in there for some companies. The coronavirus pandemic has led to a lockdown in many cities, and due to that, thousands of people are now holed up in their homes throughout the day.
Is Cronos a good pot Stock to buy?
Cronos may have the second-most cash on hand of any pure-play pot stock, but its operating performance has been abysmal. In the quarter that ended in September, Cronos produced only 11.4 million Canadian dollars ($8.9 million U.S.) in net sales and a negative gross margin.
Is medical marijuana the next big thing in the industry?
Meanwhile, 36 states in the U.S. have legalized medical marijuana, 15 of which also allow for adult-use consumption or retail sale. It's a legitimate, fast-growing business that could very well show investors the green. However, not all companies in next-big-thing industries can be winners.
Payload Stocks
Trading service that aims to speculate on small stocks that have hired “investor relations” firms to pump up their stock price.
Resource Stock Millionaire
Monthly newsletter recommending natural resource stocks, primarily in mining.
Red-Hot Small-Caps
Newsletter than presents at least one small-cap stock selection each month. It looks at minimally covered small-cap stocks.
How much cash is in canopy growth?
By the end of calendar year 2018, Canopy Growth had close to CA$5 billion in cash on its balance sheet. But by the end of September 2020, it was down to CA$1.72 billion. Mind you, this includes a CA$245 million add-on investment from Constellation earlier this year.
How many states have legalized medical marijuana?
Meanwhile, 36 states in the U.S. have legalized medical marijuana, 15 of which also allow for adult-use consumption or retail sale. It's a legitimate, fast-growing business that could very well show investors the green. However, not all companies in next-big-thing industries can be winners.
Is Hexo stock delisted?
HEXO also recently completed a 4-for-1 reverse split to avoid being delisted from the New York Stock Exchange. Here's a tip: Companies that are in solid financial shape rarely, if ever, have to worry about enacting reverse splits to avoid delisting. HEXO should be avoided in 2021. Image source: Getty Images.
Who is the CEO of Canopy Growth?
Constellation Brands has a clear vested interest in Canopy Growth's success, which is likely why its former CFO, David Klein, is now Canopy's CEO. But like Aurora, Cronos, and HEXO, Canopy Growth is failing miserably in the operating department.
Is Aurora Cannabis generating positive EBITDA?
Even if Aurora Cannabis is able to finally generate positive EBITDA after significant cost-cutting activity, it's likely years away from turning a profit. A company that's backpedaling in a fast-growing industry isn't where you want to park your money.